Literature DB >> 11874765

Sildenafil-associated nonarteritic anterior ischemic optic neuropathy.

Howard D Pomeranz1, Kyle H Smith, William M Hart, Robert A Egan.   

Abstract

PURPOSE: To describe the clinical features of five patients who developed nonarteritic anterior ischemic optic neuropathy (NAION) after ingestion of sildenafil citrate (Viagra; Pfizer Pharmaceuticals, New York, NY).
DESIGN: Retrospective observational case series. PARTICIPANTS: Five patients with NAION who reported the use of sildenafil citrate before the onset of ocular symptoms. MAIN OUTCOME MEASURES: The symptoms presented, history, ophthalmic examination, and visual field examination of each patient.
RESULTS: Nonarteritic anterior ischemic optic neuropathy developed in one eye within minutes to hours after ingestion of sildenafil. Four of the five patients had no vascular risk factors for ischemic optic neuropathy. The patients all developed unilateral blurry vision, altitudinal visual field defects, and optic disc edema. Each of the patients was noted to have a small cup-to-disc ratio in the unaffected optic nerve.
CONCLUSIONS: Sildenafil citrate may be associated with NAION. A small cup-to-disc ratio may be a risk factor for development of NAION in association with the use of sildenafil.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874765     DOI: 10.1016/s0161-6420(01)00976-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  29 in total

1.  Can erectile dysfunction drug use lead to ischaemic optic neuropathy?

Authors:  H D Pomeranz
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

2.  Hemodynamic effects of sildenafil citrate (Viagra) on segmental branches of bilateral renal arteries.

Authors:  Arslan Ardicoglu; Ercan Kocakoc; Veysel Yuzgec; Zulkif Bozgeyik; Halit Canatan; Adem Kiris
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases.

Authors:  Alberto Galvez-Ruiz; Nawal Arishi
Journal:  Saudi J Ophthalmol       Date:  2013-07-22

4.  [Side effects of erectile dysfunction drug treatment].

Authors:  H Sperling
Journal:  Urologe A       Date:  2017-04       Impact factor: 0.639

Review 5.  Drug treatment of pulmonary hypertension in children.

Authors:  Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

6.  ERG evaluation of daily, high-dose sildenafil usage.

Authors:  Christopher I Zoumalan; Roham T Zamanian; Ramona L Doyle; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2008-09-26       Impact factor: 2.379

7.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

Review 8.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 9.  Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?

Authors:  Helen V Danesh-Meyer; Leonard A Levin
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

10.  Effect of DA-8159, a selective phosphodiesterase type 5 inhibitor, on electroretinogram and retinal histology in rabbits.

Authors:  Ho Kyun Cho; Kyung Koo Kang; Gook Jun Ahn; Hyun Joo Shim; Won Bae Kim
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.